Bioproperties
Bioproperties is an Australian privately-held manufacturer of live vaccines for the food animal industry, founded in 1989 and based in Ringwood, serving veterinary and livestock customers under the leadership of founder David Tinworth.
- Company typePrivate
- Founded1989
- HeadquartersRingwood, Australia
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bioproperties does
Bioproperties is an Australian privately-held manufacturer and supplier of live vaccines targeting the food animal industry. The firm is headquartered in Ringwood, Australia, and operates with a headcount in the 51-100 employee range, consistent with a small-to-mid biologics manufacturing business. It was founded in 1989 and has remained under the leadership of its founder, David Tinworth, who serves as managing director; no public listing, funding rounds or parent-company relationships are evident in the input.
The company's core offering is live veterinary vaccines — attenuated biological products used in livestock species rather than dead/inactivated or subunit platforms. As a small Australian animal-health manufacturer, Bioproperties would be subject to Australian Pesticides and Veterinary Medicines Authority (APVMA) regulatory oversight, with potential export registrations supporting distribution beyond Australia. The technical foundations (master seed banks, cell-substrate propagation, cold-chain logistics) are characteristic of established live-vaccine producers but are not detailed in the available source material; the company website returned only a verification/loader page during data collection, so product-level specifics could not be confirmed.
Business model mechanics — pricing, channel structure, customer concentration, geographic mix — are not disclosed in the input. There is no investor commentary, third-party financial data, partnership record or M&A activity described. Consequently, the company's commercial posture should be inferred from its sector and scale: it operates as a niche B2B supplier of regulated animal-health biologics, likely selling to veterinary distributors, livestock integrators and government/industry vaccination programs in Australia and selected export markets. The data set is materially incomplete; any strategic, revenue or growth conclusion beyond this structural baseline rests on inference rather than direct evidence.
Bioproperties firmographics
Firmographics- Name
- Bioproperties
- Website
- https://bioproperties.com.au
- Company type
- Private
- Founded year
- 1989
- Headcount range
- 101–250 employees
- Short description
- Bioproperties is an Australian privately-held manufacturer of live vaccines for the food animal industry, founded in 1989 and based in Ringwood, serving veterinary and livestock customers under the leadership of founder David Tinworth.
- Ownership category
- akta.pro rank
Bioproperties industry classification
Industry- Product category
- Veterinary Biologics
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro industry
- Livestock Vaccines (Cattle, Swine, Sheep & Goats)Veterinary Vaccines (Biologics)Veterinary VaccinesVaccine Technology Platforms (Live, Inactivated, Subunit, Vector, mRNA/DNA)Veterinary Vaccine & Biologics DistributorsHealthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)Vaccine R&D, Clinical/Field Trials & Regulatory Affairs
Keywords
Where Bioproperties is headquartered
LocationHeadquarters
- HQ city
- Ringwood
- HQ country
- Australia
- HQ region
- Oceania
Markets served
Bioproperties business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Bioproperties product offering
Product offeringCore offering
Bioproperties manufactures and supplies live (attenuated) vaccines for the food animal industry. The company produces veterinary biological vaccines used by livestock and poultry producers to prevent economically significant diseases in food-producing animals, operating from its Ringwood, Australia facility. The offering is a B2B product line of biological vaccines sold to veterinary distributors and animal-health customers.
Differentiator
Problem solved
Functional benefit
Products and services
- Live vaccines for the food animal industry Live (attenuated) veterinary vaccines manufactured and supplied to commercial producers of food-producing animals such as poultry, swine, and livestock, and to veterinary distributors/integrators. Used as preventive biologicals in routine animal-health vaccination programs.
Companies that use Bioproperties
Customer profileIdeal customer profiles2 records
Bioproperties technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bioproperties partnerships and signals
Strategic signalRecent moves3 records
Bioproperties competitors and assessment
Company assessmentBroad incumbents
- Vetoquinol: French veterinary pharmaceutical company with livestock vaccine and pharmaceutical offerings. Comparable as an established mid-tier animal health company with food animal vaccine products.
- Ceva Santé Animale: Global veterinary pharmaceutical company with a significant livestock vaccine portfolio including live and inactivated products. Comparable as a multi-species animal vaccine competitor, similar in mid-tier scale relative to the largest players.
- MSD Animal Health: Animal health division of Merck, one of the largest veterinary biologics manufacturers worldwide, including live and recombinant livestock vaccines. Comparable as a global competitor in the food animal vaccine category.
- Zoetis: The world's largest animal health company, offering a broad portfolio of vaccines (including live and inactivated) for livestock and companion animals. Comparable as a competing supplier of food animal vaccines globally, though with vastly greater scale and species coverage.
- Boehringer Ingelheim Animal Health: Major animal health player with a strong portfolio of livestock vaccines, particularly for swine and poultry. Comparable as a competing food animal vaccine manufacturer with global distribution.
Direct peers
- Indian Immunologicals: Indian veterinary vaccine manufacturer producing livestock vaccines including live attenuated products for food animals. Comparable as a regional specialist with similar scale and product focus.
- HIPRA: Spanish veterinary pharmaceutical company specializing in animal vaccines, particularly for livestock and aquaculture. Closely comparable as a mid-sized specialist veterinary biologics manufacturer with a live-vaccine heritage.
Regional players
- Bioveta: Czech veterinary biologics manufacturer supplying livestock and companion animal vaccines across Central and Eastern Europe. Comparable as a mid-sized regional live-vaccine producer serving food animal markets.
- Agrolabo: Italian veterinary pharmaceutical company manufacturing vaccines and pharmaceuticals for livestock. Comparable as a mid-sized regional animal vaccine producer in Southern Europe.
- Kyoto Biken Laboratories: Japanese veterinary vaccine manufacturer focused on livestock biologics, particularly live vaccines. Comparable as a regional specialist serving food animal producers with traditional vaccine platforms.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
Bioproperties social profiles
Digital presenceBioproperties financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioproperties leadership team
Management profileNumber of profiles
Profiles1 record
Bioproperties funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioproperties M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioproperties
What does Bioproperties do?
Bioproperties manufactures and supplies live (attenuated) vaccines for the food animal industry. The company produces veterinary biological vaccines used by livestock and poultry producers to prevent economically significant diseases in food-producing animals, operating from its Ringwood, Australia facility. The offering is a B2B product line of biological vaccines sold to veterinary distributors and animal-health customers.
When was Bioproperties founded?
Bioproperties was founded in 1989. It employs 101 to 250 people.
Where is Bioproperties based?
Bioproperties is headquartered in Ringwood, Australia, in the Oceania region.
Who are Bioproperties's main competitors?
Broad incumbents on record are Vetoquinol, Ceva Santé Animale, MSD Animal Health, Zoetis and Boehringer Ingelheim Animal Health. Direct peers are Indian Immunologicals and HIPRA. Regional players are Bioveta, Agrolabo and Kyoto Biken Laboratories.
Does Bioproperties have an API?
No public API is recorded for Bioproperties.
What industry is Bioproperties in?
Bioproperties's product category is Veterinary Biologics. Its primary akta.pro industry code is HLAMAKAB, Livestock Vaccines (Cattle, Swine, Sheep & Goats), with a secondary code of HLAMAEAL, Veterinary Vaccines (Biologics). Its SIC code is 2836.